Next Article in Journal
Co-Crystallization Approach to Enhance the Stability of Moisture-Sensitive Drugs
Next Article in Special Issue
GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids
Previous Article in Journal
Green Manufacturing for Herbal Remedies with Advanced Pharmaceutical Technology
Previous Article in Special Issue
Development of Gelatin-Coated Hydrogel Microspheres for Novel Bioink Design: A Crosslinker Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 15
Issue 1
10.3390/pharmaceutics15010190
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluating the Skin Interactions and Permeation of Alginate/Fucoidan Hydrogels Per Se and Associated with Different Essential Oils

by
Ana Isabel Barbosa
1,
Sofia A. Costa Lima
2,*,
Ibraheem Yousef
3 and
Salette Reis
1
1
LAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal
2
LAQV, REQUIMTE, Departamento de Química, Instituto de Ciências Biomédicas de Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal
3
ALBA Synchrotron, Carrer de la Llum 2-26, Cerdanyola del Vallès, 08290 Barcelona, Spain
*
Author to whom correspondence should be addressed.
Pharmaceutics 2023, 15(1), 190; https://doi.org/10.3390/pharmaceutics15010190
Submission received: 3 December 2022 / Revised: 27 December 2022 / Accepted: 30 December 2022 / Published: 5 January 2023
(This article belongs to the Special Issue Hydrogels in Pharmaceutical and Biomedical Applications)
Browse Figures
Versions Notes

Abstract

:
Marine polysaccharides are recognized for their biological properties and their application in the drug delivery field, favoring hydrogel-forming capacities for cutaneous application towards several dermatological conditions. Essential oils have been widely used in skin, not only for their remarkable biological properties, but also for their capacity to enhance permeation through the skin layers and to confer a pleasant scent to the formulation. In this study, menthol, L-linalool, bergamot oil, and β-pinene were incorporated in alginate/fucoidan hydrogels to evaluate their skin permeation enhancement profile and assess their influence on the skin organization. The combinations of different essential oils with the marine-based fucoidan/alginate hydrogel matrix were characterized, resulting in formulations with pseudoplastic rheological properties favorable for a uniform application in the skin. The ex vivo Franz diffusion permeation assays revealed that calcein loaded in bergamot-alginate/fucoidan hydrogel permeated more than 15 mg out of the initial 75 mg than when in linalool-alginate/fucoidan, alginate/fucoidan or hydrogel without any incorporated oil. Skin calcein retention for menthol- and pinene-alginate/fucoidan hydrogels was 15% higher than in the other conditions. Infrared micro-spectroscopic analysis through synchrotron-based Fourier Transform Infrared Microspectroscopy evidenced a symmetric shift in CH3 groups towards higher wavenumber, indicating lipids’ fluidization and less lateral packing, characterized by a band at 1468 cm−1, with the bergamot-alginate/fucoidan, which contributes to enhancing skin permeation. The study highlights the effect of the composition in the design of formulations for topical or transdermal delivery systems.

Graphical Abstract

1. Introduction

Marine polysaccharides are often in the spotlight due to their interesting biological properties, their high bioavailability and biocompatibility, and their potential application in the field of drug delivery [1]. Divided according to their pigments (green algae, Chlorophyceae; red algae, Rhodophyceae; and brown algae, Phaeophyceae), algae are considered one of the richest polysaccharide suppliers applied in different therapeutic areas [2,3], with a clear research focus on skin health [3] through the areas of wound dressing, tissue engineering [4,5], and dermocosmetic.
Alginate and fucoidan polymers are found in brown algae and have been reported in several nanotherapeutic studies [6,7], as their effective extraction remarkably improved their application in the drug delivery field [8]. In this work, alginate/fucoidan hydrogels were prepared to study their potential application as a skin delivery system. Alginate is composed of (1,4)-linked β-d-mannuronic and α-l-guluronic monomers, rearranged in various proportions depending on the extraction source [7], with effects on its hydrogel strength, transmittance, swelling, and viscoelastic properties [9,10]. Due to its capacity to incorporate large amounts of bioactive molecules, alginate has been extensively used in the design of several delivery systems [11], particularly in hydrogel production [12,13]. The main reported alginate properties and advantages are related to its biocompatibility, biodegradability, cell affinity, strong bioadhesion, high capacity to absorb water, inert nature and non-toxicity, ease of gelation and regeneration, and capacity to activate macrophages [14,15]. Fucoidan is essentially composed of L-fucose and sulfate ester groups, presenting different biological activities dependent on its source and its molecular weight, type of sugar content, sulfation degree, molecular structure, harvesting, and extraction conditions [16]. The most reported properties are antitumor [17,18,19,20,21], antiviral [22,23], anti-inflammatory [24,25,26,27,28,29], and anticoagulant [26,30,31,32,33], but also skin management potential [34,35,36,37]. Pozharitskaya and colleagues evidenced the cutaneous application of fucoidan with pharmacokinetic studies in rats, which indicated fucoidan’s ability to cross the skin barrier and accumulate in the striated muscles [38]. In the present work, the aim is to combine fucoidan’s topical pharmacokinetic potential with the current knowledge and potentialities of using alginate in wound healing and cutaneous drug delivery [39,40] to design a hydrogel for skin delivery.
Taking advantage of the aforementioned algal polysaccharides’ properties, in particular, their individual anti-inflammatory and hydrogel-forming capacities, could be interesting to develop delivery systems for cutaneous application. Hydrogels have been described as desirable drug delivery systems when compared to other topically applied galenic forms, especially due to their higher water content, with associated cooling and hydration effects, reduced transepidermal water loss, longer drug absorption, and high skin biocompatibility [41,42]. As the largest organ in the human body, the skin is a natural barrier that protects the organism against undesirable external aggression, but it is also the major hurdle to overcome when planning drug administration through this route. Among the well-known skin layers, the stratum corneum (SC) represents challenging horizontally packed layers of dead keratinocytes (corneocytes) embedded in a lipid matrix (commonly associated with a “brick and mortar” structure) with remarkable protein complexity, adaptation, and the self-maintenance capacity of the skin barrier function [43]. Any perturbance of this well-orchestrated balance can represent a strategy to perform an effective drug delivery through the skin by enhancing the permeation of active compounds through this desirable route [44]. Skin penetration can be enhanced by interaction with lipids, either by fluidizing or disorganizing lipids, and even extracting them; by interacting with proteins; and by increasing drug solubility and partitioning in the skin [45,46,47]. These phenomena are particularly achievable with the use of chemical penetration enhancers, such as terpenes, terpenoids, and essential oils [48]. Since the isolation of essential oils and the study of their volatile compounds, several pharmaceutical applications were reported [49,50], including their use as skin penetration enhancers for transdermal drug delivery [51]. Representing a good alternative to synthetic skin penetration enhancers, essential oils are cheaper and safer due to their higher clearance of the skin. After cutaneous application, components of essential oils are rapidly metabolized, resulting in non-accumulation and rapid excretion, though more clinical trials are needed to confirm the real safety of these plant-based products’ application in humans [52]. Essential oils can penetrate through the SC and enhance the cutaneous entry of both lipophilic and hydrophilic drugs, using mechanisms of fluidization and disintegration of the intercellular robust lipid structure of corneocytes in SC, by interacting with and modifying the conformation of intercellular proteins and increasing the drug partitioning [53]. Monoterpenes and sesquiterpenes correspond to 25% of the terpene fractions in essential oils [54]. Terpenes are also known for their ability to permeate the skin’s SC, as the smaller terpenes are the ones that permeate better [55,56]. In this context, menthol, L-linalool, bergamot oil, and b-pinene were selected for incorporation in alginate/fucoidan hydrogels to address their effect as skin permeation enhancers.
One of the most widely studied terpenes in the field of skin penetration enhancement is menthol [57]. Menthol is a cyclic monoterpene that was found to disrupt the intercellular lipids of SC, revealing changes in infrared spectra and X-ray diffraction patterns of SC, and consequently enhancing the skin permeation of the indomethacin by higher concentration and diffusion rate in the skin [58]. Recent studies show that menthol can be incorporated in the matrix of nanoparticles [59] and hydrogels [60] to work as skin permeation enhancers, and this effect is more evident in a concentration-dependent manner [61]. L-linalool is an acyclic terpene alcohol extracted from aromatic plants [62]. Linalool was found to improve the percutaneous absorption of propranolol [57] and was tested among other terpenes to improve the skin permeation active agents from tea (catechins and theophylline), showing one of the highest sets of results for flux, skin deposition, and enhancement ratios [63]. Linalool and linalyl acetate were comparatively studied due to their similar scent and anti-inflammatory properties [64]. In fact, some authors stated the hypothesis that linalool and linalyl acetate can be formulated in the same vehicle for the useful treatment of inflammation scenarios [65]. Bergamot oil is a commercially available essential oil extracted from Citrus bergamia, and it is mainly composed of limonene, linalyl acetate, and linalool [66]. A study disclosed the antinociceptive effect of bergamot oil and linalool after the intra-plantar combined injection of bergamot oil and capsaicin in mouse hind paw [67]. Associating the proven skin permeation enhancement effect of linalool and linalyl acetate, as well as their anti-inflammatory properties, the use of bergamot oil can be a good strategy to treat inflammation and overcome the skin barrier. Another minor component of bergamot oil with potential application in cutaneous penetration enhancement is b-pinene, which is a bicyclic monoterpene mostly found in pine essential oils, with interesting pharmacological effects, such as antioxidant, anti-inflammatory, and analgesic effects [68]. A comparative study performing in vitro human skin permeation of monoterpenes has shown that the apparent permeability coefficients of β-pinene were four times higher than other terpenes (e.g., β-myrcene, limonene, and α-pinene) [69]. This study aimed to unravel and evaluate the mechanism of the inherent permeation profile of marine polymeric hydrogels per se and associated with menthol, linalool, bergamot oil, and pinene, which belong to the class of skin penetration enhancers. This study involved the hydrogel’s physicochemical characterization and ex vivo skin permeation assays of calcein, a model compound that is commonly used to validate the effect of differently skin-targeted platforms of the proposed model [70,71,72]. To study skin organization regarding lipid and protein structures, infrared spectroscopic analysis through synchrotron-based Fourier Transform Infrared Microspectroscopy (SR-FTIRM) was performed for the SC layer, the first hurdle to overcome in order to achieve cutaneous delivery.

2. Materials and Methods

2.1. Materials

Fucoidan extracted from Fucus vesiculosus (92.9% fucoidan phytonutrient content, high molecular weight, code 5619002900, batch FVF2016507) was a kind gift from Kraeber & Co. GMBH (Ellerbek, Germany). Sodium alginate (from Lessonia nigrescens, code 177775000, lot A0376873, sulfated ash 34.16% (on dried substance)) was purchased from ACROS OrganicsTM (Thermo Fisher Scientific, Waltham, MA, USA). (−)-Menthol was acquired from Fluka (Buchs, Switzerland). Bergamot oil was purchased from Pranarôm (Ghislenghien, Belgium). L-Linalool, (−)-β-pinene, calcein, 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) hemisodium salt, and trypsin (from the porcine pancreas) were acquired from Sigma-Aldrich (St. Louis, MO, USA). The porcine ears were purchased at a local slaughter (Porto, Portugal). Double-deionized water was provided by an ultra-pure water system (Arium Pro, Sartorius AG, Gottingen, Germany). The reagents were weighted in a digital analytical balance Kern ACJ/ACS 80-4 (Kern & Sohn; Balingen, Germany). All other reagents were analytical grade and were used without any further purification.

2.2. Preparation of Hydrogels

For hydrogel preparation, and based on different percentage combinations of both polymers, 1% (w/v) sodium alginate and 2% (w/v) fucoidan were simultaneously dissolved in double-deionized water, as a way to obtain a higher amount of the sulfated polysaccharide in the matrix and to have a concentration of the carboxylated polysaccharide able to achieve gelation. After complete dissolution, 1% (w/v) of each essential oil was used to enrich the hydrogels, using 5 min vortex to facilitate its incorporation in the matrix. In calcein-loaded hydrogels, 1% (w/w) of calcein was also added to the hydrogel blend in the dissolution step. After each hydrogel preparation, the final pH was measured with a Crison pH meter GLP 22 with a Crison 52-02 tip (Crison; Barcelona, Spain).

2.3. Physicochemical Characterization of Hydrogels

2.3.1. Morphological Analysis

The hydrogels were frozen overnight at −80 °C (Deep Freezer, GFL®, Burgwedel, Germany) and then lyophilized using a freeze drier (LyoQuest -85 plus v.407, Telstar® Life Science Solutions, Terrassa, Spain) for 72 h at −80 °C under 0.40 mbar of pressure. The freeze-dried hydrogels were analyzed by Scanning Electron Microscopy (SEM) using a FEI Quanta 400 FEG ESEM/EDAX Pegasus X4M with an accelerating voltage of 10 kV. Hydrogels were fixed onto carbon-taped metal pins and coated with Au/Pd by sputtering for 45 s.

2.3.2. Differential Scanning Calorimetry Analysis

Measurements were performed using a differential scanning calorimeter (DSC 200 F3 Maia Netzsch). Approximately 5–10 mg of all individual components and freeze-dried hydrogels were weighed in aluminum pans and sealed. An empty aluminum pan was used as a reference. Heating curves were recorded with a heating rate of 10 K/min from −40 °C to 300 °C and software provided by the DSC equipment (NETZSCH Proteus® Software—Thermal Analysis—Version 6.1).

2.3.3. Rheology Studies

The rheological properties of the prepared hydrogels were analyzed on a rheometer (Malvern Kinexus Lab+; Malvern Instruments; Worcestershire, UK) using four different methods. For viscosimetry, a shear rate table method (0.1 to 100.0 s−1, 10 samples per decade, 25 °C) was used. The thixotropy test followed a three-step shear rate method (1st phase: 0.1 s−1, 2 min; 2nd phase: 100.0 s−1, 30 s; 3rd phase: 0.1 s−1, 15 min, 25 °C). To determine the linear viscoelastic region, an amplitude sweep method was performed (0.1 to 100%, 10 samples per decade, 1.0 Hz, 25 °C). Finally, to address the temperature effect, a single frequency temperature ramp was used (initial temperature 20 °C, final temperature 40 °C, 2 °C/minute ramp, frequency 1 Hz). All analysis was conducted with a plate-plate configuration (geometry CP4/40 SR4321) with a 1 mm gap (Peltier Plate Cartridge). All experiments were performed in triplicate, and data were collected using the rSpace software® (Kinexus 1.75: PSS0211-17).

2.4. Ex Vivo Skin Permeation Assays

The ex vivo skin permeation assays were performed using porcine ear skin as a barrier. The skin was obtained from a local butcher, immediately detached using a scalpel, cleaned, and stored in plastic bags at −20 °C. The assay was performed in a Franz cell assembly (9 mm unjacketed Franz Diffusion Cell with 5 mL receptor volume, O-ring joint, clear glass, clamp, and stir-bar; PermeGear, Inc., Hellertown, PA, USA). A volume of 250 µL of the hydrogels or free calcein corresponding to 75 µg was placed on top of the full skin. The receptor chamber was filled with HEPES buffer, pH 7.4, and was kept at 37 °C and stirred at 400 rpm during the assay. At the end of the assay, the amount of calcein in the donor and receptor compartments was determined by spectrofluorimetry (excitation and emission wavelengths at 495 nm and 517 nm, respectively) to overcome interferences from skin components released during the experiment. The amount of calcein retained in the skin was calculated considering the difference between the initial amount of calcein added to the donor compartment and the quantified amount at the end of the assay in the receptor compartment. The permeability results were expressed in the percentage of release and apparent permeability (Papp). Papp was calculated using the following equation:
P app   cm / s = ∑ m a A × m d × t
where the sum of ma is the mass of calcein permeated across the skin layer in the receptor chamber, A is the diffusion area between cells in the Franz diffusion system (0.64 cm2), md is the initial mass of calcein in the donor chamber, and t is the time (24 h = 86,400 s).

2.5. Synchrotron-Based Fourier Transform Infrared Microspectroscopy

2.5.1. Experimental Setup for SR-FTIRM Samples

Frozen porcine ear skin was cut as discs of 12 mm diameters, thawed at room temperature, placed in 24-well plates, and distributed considering the experimental groups: control (untreated), essential oils, hydrogel (without essential oils), and essential-oil-enriched hydrogels. Each disc was treated by applying 40 µL of each sample, enough to cover the area of the skin. All discs were incubated at room temperature for 24 h. After an incubation period, the excess of the sample was removed with a swab, and the skin was gently washed with a cotton swab impregnated with ultrapure water before further processing. The treated skin samples were frozen in liquid nitrogen before cutting in a cryostat in sections of 5 µm thickness and placed on CaF2 circular windows (Crystran Ltd., Poole, UK) for analysis under the synchrotron-based Fourier Transform Infrared Microspectroscopy (SR-FTIRM).

2.5.2. Infrared Microspectroscopy at Synchrotron

The infrared microspectroscopy analysis was performed at the MIRAS beamline at the ALBA synchrotron (Cerdanyola del Vallès, Spain). The measurements were obtained using the 3000 Hyperion microscope coupled to a Vertex 70 spectrometer, equipped with a liquid nitrogen-cooled mercury cadmium telluride 50 m MCT-A detector. The spectra were collected using a Schwarzschild 36× magnification objective (0.52 NA) coupled to a 36× magnification condenser, with a single masking projected aperture size on the sample of 10 × 10 µm2 and step size of 5 × 5 µm2. Raster scan map measurements of a selected area on the skin were obtained in the 4000–900 cm−1 mid-infrared range at a spectral resolution of 4 cm−1, with 64 co-added scans per spectrum at room temperature in transmission mode. A background spectrum was collected every 15 measurements to eliminate the residual contamination (water vapor, CO2) of the room ambient. To extract spectral information, each spectrum was manually grouped considering the SC layer. Data treatment and statistical analysis were conducted as previously described using OPUS (Bruker, Billerica, MA, USA) and Unscrambler® (CAMO software, Oslo, Norway) software [73,74].

2.6. Statistical Analysis

Statistical analysis was performed using GraphPad Prism Software (Version 6.01 for Windows; GraphPad Software Inc., San Diego, CA, USA). The One-Way ANOVA following Tukey’s multiple comparison test was performed to evaluate differences in pH values of all hydrogels, and also to compare free calcein and calcein-loaded hydrogels in the ex vivo permeation assay. Differences were considered significant at p < 0.05.

3. Results and Discussion

3.1. Characterization of Hydrogels

Addressing the skin pH should be a priority when designing skin formulations, and controlling its pH is a crucial and tunable step to accomplish higher skin penetration. For all hydrogels, the pH was determined in three independent batches. Alginate/fucoidan presented a pH value of 5.34 ± 0.18, and the inclusion of essential oils slightly lowers this value. Compared with alginate/fucoidan, menthol-alginate/fucoidan and pinene-alginate/fucoidan hydrogels present a similar pH value (5.20 ± 0.02 and 5.12 ± 0.01, respectively), but there is a statistical difference (** p < 0.01) obtained for linalool- and bergamot-alginate/fucoidan hydrogels with pH values below 5 (4.95 ± 0.02 and 4.96 ± 0.10, respectively). Skin is the first barrier that confers protection from external aggressions, and its microbiome and integrity are in a complex balance between several factors. The changes in skin pH can have pathogenetic consequences, leading to impaired skin barrier function and bacterial colonization [75]. The maintenance of an acidic pH is crucial for normal SC lipid organization and lipid metabolism [76]. The effective skin pH results from the interplay between the active compound, the formulation used in its delivery, and also the actual skin pH value [77]; hence, all these acidic hydrogel formulations might help re-establishing skin pH below 5, which is ideal for its native microbiome, with and without essential oils in its matrix [78].
The morphological analysis of all the designed hydrogels resulted in the scanning electron microscopy (SEM) micrographs shown in Figure 1. Considering the first set of images with a scale bar corresponding to 500 µm, the similarity in terms of macrostructure can be confirmed for all analyzed samples. The obtained branched scaffolds have also been described in previously freeze-dried formulations containing fucoidan and alginate [79]. Within the microstructure of the linalool-, bergamot-, and pinene-alginate/fucoidan hydrogels, observed with local amplification (Figure 1, second set of images, with a scale bar corresponding to 20 µm), it is possible to observe the presence of pores, evidenced with arrows. The essential oil droplets in the hydrogel matrix, upon freeze-drying, may result in these structures. The presence of pores might represent a good strategy to promote the controlled release of active substances from the hydrogel material, as well as serve as a hydrogel-incorporated platform to entrap hydrophobic compounds with good affinity to the oil phase [80].
Also from SEM analysis, it was possible to observe crystalized menthol on the microstructure of menthol-alginate/fucoidan hydrogel. This was further evaluated by differential scanning calorimetry (DSC) analysis of all samples to determine the existence of phase transitions. The heat flow curves were obtained for all individual components used in the preparation of the hydrogels (Figure 2a). The alginate heat flow curve indicates some residual water evaporation after 100 °C, melting exothermic peaks between 225 and 240 °C, and degradation around 260 °C [81]. The residual water evaporation can also be found in fucoidan polymer, as well as a degradation-related exothermic peak around 170 °C [82]. Menthol exhibited a melting endothermic transition peak around 35–40 °C and another around 200 °C, which can be attributed to thermal oxidation [83]. Linalool, bergamot, and pinene oil curves showed endothermic peaks at about 205, 210, and 170 °C, respectively [84,85]. The thermal behavior of all hydrogels (Figure 2b) also revealed the evaporation of residual water present in the matrix, but the individual characteristic peaks from the essential oils were not so evident in the heat flow curves, suggesting a complex formation and a successful embedding of the essential oils in the hydrogel matrix, comparable with the alginate/fucoidan platform [85,86].

3.2. Hydrogels’ Rheological Analysis

Aiming for a cutaneous application and to understand how the designed hydrogels will flow through the skin, a rheological analysis was performed for all samples. Regarding viscosimetry analysis (Figure 3), all hydrogels have similar initial viscosity, being higher in the case of menthol-alginate/fucoidan. Despite this difference, a shear thinning behavior is observed in all hydrogels. Since shear stress increases and shear viscosity decreases with increasing shear rate in all evaluated samples, the hydrogels are characterized by a pseudoplastic behavior. Pseudoplasticity indicates that a viscous formulation under static conditions will become less viscous after the application of shear stress, which will represent the motion of hydrogel application in the skin [87]. This property allows a higher spreadability of the formulation, enhancing uniform distribution in the skin [88] and contributing to a higher permeation of the active substances upon cutaneous application [87].
In all analyzed samples, the initial viscosity (Figure 4) is not completely re-established during the rebuild time, after a high shear was applied to induce extreme stress conditions (Figure S1). This suggests a non-thixotropic profile of all hydrogels because the initial viscosity is higher than the one obtained by the recovered hydrogel matrix. The complex thixotropy of the essential-oil-enriched hydrogels might represent an interesting characteristic for the design of novel pharmaceutical formulations, particularly in skin formulations, determining the spreadability and interplay between the formulation and different skin layers [89] once the hydrogel structure is still maintained, even though with lower viscosity values.
All samples were also submitted to a temperature ramp set from 20 to 40 °C to evaluate their resistance by monitoring changes in elastic and viscous modulus. Analyzing the temperature ramp in all hydrogels (Figures S2 and S3), a slight viscosity reduction due to temperature increase is visible, which is a general effect in all tested formulations. There is great resistance to temperature increase in all hydrogels, except for menthol-alginate/fucoidan, which reflects a possible phase transition behavior around 34 °C, as evidenced by the menthol heat flow curve. Apart from the previous, the designed hydrogels might be stored within the set temperature range, and skin temperature might not be a crucial factor to change its initial properties [90]. These hydrogels’ capacity to maintain their characteristics in the set temperature range will be important for predicting the formulation behavior upon skin application, normally at 32 °C.

3.3. Hydrogels-Skin Interaction Studies

3.3.1. Ex Vivo Skin Permeation

The Franz cell diffusion assays were performed to evaluate the permeation of calcein from the designed hydrogels through full ex vivo pig ear skin. The pig ear is an interesting model to consider due to its similarity with human skin in terms of morphology and function [91,92], used without major ethical constraints. The use of some essential oils has been reported not only to achieve higher skin permeation—optimal for a transdermal delivery—but also to obtain higher retention in skin layers when a local effect is required [93,94]. The results reveal an increase in the permeation of calcein upon incorporation in some of the essential-oil-enriched alginate/fucoidan hydrogels at the end of 24 h assay, as expressed by apparent permeability data (Figure 5). The bergamot-alginate/fucoidan hydrogel permeates to a higher extent through the pig ear skin, followed by linalool-alginate/fucoidan and alginate/fucoidan hydrogels. Favoring the highest permeation enhancement, bergamot oil has also been studied for its antimicrobial effects on bacteria commonly involved in skin diseases [95]. In the cases of alginate/fucoidan, linalool-alginate/fucoidan, and bergamot-alginate/fucoidan, the Papp is statistically higher than free calcein. However, there is no statistical difference between these three samples, indicating that alginate/fucoidan hydrogel permeates the skin layers independently of the presence of these essential oils. Considering skin retention, menthol-alginate/fucoidan and pinene-alginate/fucoidan are the platforms that can retain up to 36% and 34%, respectively, of the initial amount of calcein, while the other platforms retain calcein up to 20% of the initial amount. Particularly in the case of menthol, this oil has been used to improve not only skin penetration, but also drug retention in skin appendages for a local effect [96]. The differential outcomes both in permeation and retention according to the essential oil used might help to design local or transdermal delivery of active compounds.

3.3.2. Synchrotron-Based Fourier Transform Infrared Microspectroscopy of SC

Epidermal SC lipids are evenly distributed between free fatty acids, cholesterol, and ceramides, constituting a well-organized barrier to prevent water loss, microorganism infections, and general external aggressions [97]. This layer represents the first challenge to overcome to achieve cutaneous delivery. The SR-FTIRM analysis was explored as a high spatial resolution tool to understand the effect of essential oils as SC permeation enhancers alone, or in combination with the designed marine polymer-based hydrogel. In skin’s unique infrared fingerprint, it is possible to identify the long alkyl chains vibrations (2800–3000 cm−1), particularly asymmetric CH2 stretching (2920 cm−1) and symmetric CH2 stretching (2850 cm−1), whose changes elucidate the chain conformation, organization, and order of SC lipids [46,98]. Different phase transitions can be identified by the chain conformation and lateral packing of lipids, namely: orthorhombic phase, with all-trans aliphatic chains and rectangular crystalline lattice packing; hexagonal phase, with all-trans aliphatic tilted chains and less dense lattice packing; and liquid crystalline phase, governed by gauche isomerization and loss of laterally organized lattice packing [46]. Hence, skin penetration enhancers might fluidize lipids, promoting higher fluidity and flexibility of the alkyl chains, evidenced by higher frequencies and broader peak widths, and the opposite is evidenced by peaks at lower wavenumbers when a more ordered state takes place [99].
The analysis of significant changes regarding lipid stretching revealed that oils and essential-oil-enriched hydrogels alter lipid chain conformation towards lower fluidity, particularly evidenced by changes in CH2 symmetric and asymmetric stretching towards lower wavenumbers (Table 1). Besides these changes toward lower fluidity, bergamot-alginate/fucoidan also reveals a symmetric shift in CH3 groups towards higher wavenumber, indicating possible fluidization of the lipid matrix, thus explaining the higher permeation extent described in skin permeation studies.
The lipid lateral packing and integrity were studied through manifestations in lipid scissoring, addressing significant changes between 1480 and 1460 cm−1 [100]. A hexagonal packing of lipids is characterized by a band at 1468 cm−1, while the orthorhombic packing is identified by two components at 1472 cm−1 and 1464 cm−1 [76]. All essential oils and essential-oil-enriched hydrogels evidence the band at the 1468 cm−1 band, representing a hexagonal packing of lipids (Table S1). The band around 1454 cm−1 is related to the C–H bending in CH3 groups. Overall, samples manifest a band shift in this area when compared to untreated sample, corroborating the observed band shifts obtained in lipid CH3 stretching. However, it is important to point out the higher wavenumber for bergamot-alginate/fucoidan, which is consistent with the observed higher lipid stretching vibration wavenumbers. These changes in lateral packing suggest a higher fluidity and compromised barrier integrity after skin treatment with this hydrogel. This is also consistent with lipid stretching information, indicating that bergamot-alginate/fucoidan will diffuse better through the SC, increasing its permeation through the skin layers.
Protein alterations can be identified between the range of 1400 to 1800 cm−1, with major contributions from amide I (1600–1700 cm−1) and amide II (1480–1600 cm−1) bands. Keratin is the main protein in surface skin, and secondary structure and conformation can be monitored through changes in the amide I. Analyzing structural changes in proteins (Figure 6), no significant changes were found for amide I or amide II characteristic peaks of keratin, suggesting that the essential oils or hydrogel samples do not affect the protein component of SC.
SC keratin presents an α-helix secondary structure, and if this conformation is disturbed, changes in the amide I can be observed [74,101]. As previously mentioned, the denaturation of keratin can be a mechanism of penetration enhancement. Due to this ability to disrupt ordered SC lipid bilayers or force protein-mediated partition or denaturation in a concentration-dependent manner, skin penetration enhancers can be classified as cytotoxic, irritant, and allergenic [53]. The goal is to achieve penetration potency without compromising skin safety. In this context, all of the designed essential-oil-enriched hydrogels can be considered non-irritant because no structural changes take place.
In order to explain the mechanisms behind penetration enhancers, Brian Barry enounced the Lipid Protein Partition theory of skin penetration enhancement [102], on which this study was based. Skin permeation can occur through sweat pores and hair shafts, but mainly through intact skin SC, paving the path within the intercellular, intracellular, and transappendageal routes [47]. As such, compounds can interact with lipids, favoring their best affinity either to aqueous regions among polar head groups or among lipophilic regions of the alkyl chain bilayers. Corneocytes are the major components of SC, having keratin in their composition. As penetration enhancement can also occur by protein modifications, the partition theory considers the major alterations in lipid and protein structures, as well. Studies refer to the use of terpenes to fluidize and disorganize the SC, but other enhancer effects can be the promotion of lipid extraction, an increase of drug solubility and partition among lipidic bilayers, and even keratin disruption and detachment, causing defects in the normally tightly packed corneocytes [48]. Regarding synchrotron microspectroscopy analysis, the lipid structure of SC is not altered after treatment with the defined amounts of hydrogels or essential oils, except for the bergamot-alginate/fucoidan formulation. This is an interesting outcome when the aim is to fluidize the lipidic matrix to achieve higher penetration, but it could suggest that skin might be compromised or sensitized, as decreased lipid content or shorter lipid chains are common in skin diseases [103]. The absence of keratin alterations is also a positive indicator of the safe application of these marine-based polysaccharide combinations. Alginate/fucoidan with or without the essential oils can be applied as topical products without causing protein denaturation or disruption because keratin is responsible for maintaining the architecture and differentiation of epithelial cells, protecting the structural integrity of tissues, and promoting wound healing [104].

4. Conclusions

This study focused on the addition of 1% (w/v) of menthol, linalool, bergamot oil, and pinene to an alginate/fucoidan hydrogel matrix in order to study the permeation effects and skin interactions of the marine polymers per se or in combination with permeation enhancers. The pH values around 5 of the natural compounds-based hydrogels might help to balance the skin environment to optimal conditions in order to fight dysbiosis of inflamed skin, and with a rheological performance allowing a uniform spreadability of the formulation, promoting higher dermal permeation. Permeation studies in pig ear skin revealed that bergamot-alginate/fucoidan, linalool-alginate/fucoidan, and alginate/fucoidan improved full skin permeation of calcein when compared to the delivery of the free compound, while menthol- and pinene-alginate/fucoidan hydrogels favored calcein’s skin retention, optimal for a local delivery effect, with the controlled systemic distribution. The high skin permeation of calcein resulting from the application of alginate/fucoidan hydrogel also highlights its possible use as a platform for skin delivery, regardless of the addition of any penetration enhancer. SR-FTIRM data suggested that all essential oils and hydrogel formulations kept the SC lipid organization, only evidencing higher lipid fluidity and a less laterally packed lipid membrane after treatment with bergamot-alginate/fucoidan. This is consistent with the higher apparent permeability value obtained in the ex vivo pig skin Franz permeation result for bergamot-alginate/fucoidan, which can also suggest possible skin sensitization. As protein conformations are maintained in all hydrogels, these systems can also be considered non-irritant, a hypothesis that can be confirmed in the future with test guidelines on the safety of chemicals and mixtures following methods that closely mimic the biochemical and physiological properties of human skin. Further studies regarding the potential anti-inflammatory effect of the designed hydrogels and the absence of irritation and skin sensitization might help to reinforce the use of these formulations in future cutaneous delivery applications.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/pharmaceutics15010190/s1, Table S1. Evaluation of lipid scissoring band shifts in all essential oils and essential oil-enriched hydrogels in comparison to the untreated sample. Figure S1. Analysis of (a) viscosity as a function of shear rate of alginate/fucoidan (black), menthol-alginate/fucoidan (blue), linalool-alginate/fucoidan (magenta), bergamot-alginate/fucoidan (red) and pinene-alginate/fucoidan (green). Calculated values of initial (minimum shear rate—0.1 s−1) and final (maximum shear rate—100 s−1) viscosity (b). Data expressed as mean ± SD of n = 3 different hydrogel batches. Figure S2. Resistance to deformation analysis from determination of linear viscoelastic region of (a) alginate/fucoidan, (b) menthol-alginate/fucoidan, (c) linalool-alginate/fucoidan, (d) bergamot-alginate/fucoidan and (e) pinene-alginate/fucoidan. Data expressed as mean ± SD of n = 3 different hydrogel batches. Figure S3. Resistance to temperature ramp from 20 to 40 °C of (a) alginate/fucoidan, (b) menthol-alginate/fucoidan, (c) linalool-alginate/fucoidan, (d) bergamot-alginate/fucoidan and (e) pinene-alginate/fucoidan. Data expressed as mean ± SD of n = 3 different hydrogel batches.

Author Contributions

Conceptualization, A.I.B., S.A.C.L. and S.R.; methodology, A.I.B. and I.Y.; validation, S.A.C.L., I.Y. and S.R.; formal analysis, A.I.B. and S.A.C.L.; resources, S.A.C.L. and I.Y.; writing—original draft preparation, A.I.B. and S.A.C.L.; writing—review and editing, I.Y., S.A.C.L. and S.R.; supervision, S.A.C.L. and S.R.; project administration, S.R.; funding acquisition, I.Y., S.A.C.L. and S.R. All authors have read and agreed to the published version of the manuscript.

Funding

This work received financial support from PT national funds (FCT/MCTES, Fundação para a Ciência e Tecnologia and Ministério da Ciência, Tecnologia e Ensino Superior) through grants UID/QUI/50006/2020 from the European Union (FEDER funds through COMPETE PO-CI-01-0145-FEDER-030834) and National Funds (FCT, Fundação para a Ciência e Tecnologia) through project PTDC/QUI-COL/30834/2017. S.A.C.L. thanks funding from FCT/MEC (CEECINST/00007/2021), financed by national funds. A.I.B. thanks her funding from FCT/MEC (SFRH/BD/147038/2019).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors acknowledge the collaboration of ALBA staff in performing FTIR microspectroscopy at the MIRAS beamline at ALBA Synchrotron. Rheological evaluations were performed at Departamento de Ciências do Medicamento, Faculty of Pharmacy of the University of Porto, and the technical support of Paulo Costa is acknowledged.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Cardoso, M.J.; Costa, R.R.; Mano, J.F. Marine Origin Polysaccharides in Drug Delivery Systems. Mar. Drugs 2016, 14, 34. [Google Scholar] [CrossRef] [Green Version]
  2. De Jesus Raposo, M.F.; de Morais, A.M.; de Morais, R.M. Marine polysaccharides from algae with potential biomedical applications. Mar. Drugs 2015, 13, 2967–3028. [Google Scholar] [CrossRef] [Green Version]
  3. Kim, J.H.; Lee, J.E.; Kim, K.H.; Kang, N.J. Beneficial effects of marine algae-derived carbohydrates for skin health. Mar. Drugs 2018, 16, 459. [Google Scholar] [CrossRef] [Green Version]
  4. Andryukov, B.G.; Besednova, N.N.; Kuznetsova, T.A.; Zaporozhets, T.S.; Ermakova, S.P.; Zvyagintseva, T.N.; Chingizova, E.A.; Gazha, A.K.; Smolina, T.P. Sulfated Polysaccharides from Marine Algae as a Basis of Modern Biotechnologies for Creating Wound Dressings: Current Achievements and Future Prospects. Biomedicines 2020, 8, 301. [Google Scholar] [CrossRef] [PubMed]
  5. Kuznetsova, T.A.; Andryukov, B.G.; Besednova, N.N.; Zaporozhets, T.S.; Kalinin, A.V. Marine algae polysaccharides as basis for wound dressings, drug delivery, and tissue engineering: A review. J. Mar. Sci. Eng. 2020, 8, 481. [Google Scholar] [CrossRef]
  6. Chollet, L.; Saboural, P.; Chauvierre, C.; Villemin, J.N.; Letourneur, D.; Chaubet, F.; Laurienzo, P. Fucoidans in nanomedicine. Mar. Drugs 2016, 14, 145. [Google Scholar] [CrossRef] [Green Version]
  7. Lee, K.Y.; Mooney, D.J. Alginate: Properties and biomedical applications. Prog. Polym. Sci. 2012, 37, 106–126. [Google Scholar] [CrossRef] [Green Version]
  8. Dobrinčić, A.; Balbino, S.; Zorić, Z.; Pedisić, S.; Kovačević, D.B.; Garofulić, I.E.; Dragović-Uzelac, V. Advanced technologies for the extraction of marine brown algal polysaccharides. Mar. Drugs 2020, 18, 168. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Draget, K.I.; Bræk, G.S.; Smidsrød, O. Alginic acid gels: The effect of alginate chemical composition and molecular weight. Carbohydr. Polym. 1994, 25, 31–38. [Google Scholar] [CrossRef]
  10. Draget, K.I.; Skjåk-Bræk, G.; Christensen, B.E.; Gåserød, O.; Smidsrød, O. Swelling and partial solubilization of alginic acid gel beads in acidic buffer. Carbohydr. Polym. 1996, 29, 209–215. [Google Scholar] [CrossRef]
  11. Tønnesen, H.H.; Karlsen, J. Alginate in Drug Delivery Systems. Drug Dev. Ind. Pharm. 2002, 28, 621–630. [Google Scholar] [CrossRef]
  12. Augst, A.D.; Kong, H.J.; Mooney, D.J. Alginate hydrogels as biomaterials. Macromol. Biosci. 2006, 6, 623–633. [Google Scholar] [CrossRef] [PubMed]
  13. Kaczmarek-Pawelska, A. Alginate-Based Hydrogels in Regenerative Medicine; IntechOpen: London, UK, 2019; pp. 1–16. [Google Scholar] [CrossRef] [Green Version]
  14. Puscaselu, R.G.; Lobiuc, A.; Dimian, M.; Covasa, M. Alginate: From Food Industry to Biomedical Applications and Management of Metabolic Disorders. Polymers 2020, 12, 2417. [Google Scholar] [CrossRef]
  15. Yang, D.; Jones, K.S. Effect of alginate on innate immune activation of macrophages. J. Biomed. Mater. Res. Part A 2009, 90, 411–418. [Google Scholar] [CrossRef]
  16. Li, B.; Lu, F.; Wei, X.; Zhao, R. Fucoidan: Structure and bioactivity. Molecules 2008, 13, 1671–1695. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Rui, X.; Pan, H.F.; Shao, S.L.; Xu, X.M. Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: Possible JAK-STAT3 pathway. BMC Complement. Altern. Med. 2017, 17, 378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Atashrazm, F.; Lowenthal, R.M.; Woods, G.M.; Holloway, A.F.; Dickinson, J.L. Fucoidan and cancer: A multifunctional molecule with anti-tumor potential. Mar. Drugs 2015, 13, 2327–2346. [Google Scholar] [CrossRef] [Green Version]
  19. Vishchuk, O.S.; Ermakova, S.P.; Zvyagintseva, T.N. The fucoidans from brown algae of Far-Eastern seas: Anti-tumor activity and structure-function relationship. Food Chem. 2013, 141, 1211–1217. [Google Scholar] [CrossRef]
  20. Takeda, K.; Tomimori, K.; Kimura, R.; Ishikawa, C.; Nowling, T.K.; Mori, N. Anti-tumor activity of fucoidan is mediated by nitric oxide released from macrophages. Int. J. Oncol. 2012, 40, 251–260. [Google Scholar] [CrossRef]
  21. Lin, Y.; Qi, X.; Liu, H.; Xue, K.; Xu, S.; Tian, Z. The anti-cancer effects of fucoidan: A review of both in vivo and in vitro investigations. Cancer Cell Int. 2020, 20, 154. [Google Scholar] [CrossRef]
  22. Ponce, N.M.A.; Pujol, C.A.; Damonte, E.B.; Flores, M.L.; Stortz, C.A. Fucoidans from the brown seaweed Adenocystis utricularis: Extraction methods, antiviral activity and structural studies. Carbohydr. Res. 2003, 338, 153–165. [Google Scholar] [CrossRef] [PubMed]
  23. Trinchero, J.; Ponce, N.M.A.; Córdoba, O.L.; Flores, M.L.; Pampuro, S.; Stortz, C.A.; Salomón, H.; Turk, G. Antiretroviral activity of fucoidans extracted from the brown seaweed Adenocystis utricularis. Phytother. Res. 2009, 23, 707–712. [Google Scholar] [CrossRef]
  24. Park, H.Y.; Han, M.H.; Park, C.; Jin, C.Y.; Kim, G.Y.; Choi, I.W.; Kim, N.D.; Nam, T.J.; Kwon, T.K.; Choi, Y.H. Anti-inflammatory effects of fucoidan through inhibition of NF-κB, MAPK and Akt activation in lipopolysaccharide-induced BV2 microglia cells. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2011, 49, 1745–1752. [Google Scholar] [CrossRef]
  25. Barbosa, A.I.; Lima, S.A.C.; Reis, S. Development of methotrexate loaded fucoidan/chitosan nanoparticles with anti-inflammatory potential and enhanced skin permeation. Int. J. Biol. Macromol. 2019, 124, 1115–1122. [Google Scholar] [CrossRef]
  26. Pozharitskaya, O.N.; Obluchinskaya, E.D.; Shikov, A.N. Mechanisms of Bioactivities of Fucoidan from the Brown Seaweed Fucus vesiculosus L. of the Barents Sea. Mar. Drugs 2020, 18, 275. [Google Scholar] [CrossRef]
  27. Ahmad, T.; Eapen, M.S.; Ishaq, M.; Park, A.Y.; Karpiniec, S.S.; Stringer, D.N.; Sohal, S.S.; Fitton, J.H.; Guven, N.; Caruso, V.; et al. Anti-Inflammatory Activity of Fucoidan Extracts In Vitro. Mar. Drugs 2021, 19, 702. [Google Scholar] [CrossRef] [PubMed]
  28. Obluchinskaya, E.D.; Pozharitskaya, O.N.; Shikov, A.N. In Vitro Anti-Inflammatory Activities of Fucoidans from Five Species of Brown Seaweeds. Mar. Drugs 2022, 20, 606. [Google Scholar] [CrossRef]
  29. Apostolova, E.; Lukova, P.; Baldzhieva, A.; Delattre, C.; Molinié, R.; Petit, E.; Elboutachfaiti, R.; Nikolova, M.; Iliev, I.; Murdjeva, M.; et al. Structural Characterization and In Vivo Anti-Inflammatory Activity of Fucoidan from Cystoseira crinita (Desf.) Borry. Mar. Drugs 2022, 20, 714. [Google Scholar] [CrossRef]
  30. Juenet, M.; Aid-Launais, R.; Li, B.; Berger, A.; Aerts, J.; Ollivier, V.; Nicoletti, A.; Letourneur, D.; Chauvierre, C. Thrombolytic therapy based on fucoidan-functionalized polymer nanoparticles targeting P-selectin. Biomaterials 2018, 156, 204–216. [Google Scholar] [CrossRef]
  31. da Silva, L.; Todaro, V.; do Carmo, F.A.; Frattani, F.S.; de Sousa, V.P.; Rodrigues, C.R.; Sathler, P.C.; Cabral, L.M. A promising oral fucoidan-based antithrombotic nanosystem: Development, activity and safety. Nanotechnology 2018, 29, 165102. [Google Scholar] [CrossRef] [PubMed]
  32. Mourão, P.A.S. Perspective on the use of sulfated polysaccharides from marine organisms as a source of new antithrombotic drugs. Mar. Drugs 2015, 13, 2770–2784. [Google Scholar] [CrossRef] [Green Version]
  33. Mourão, P.A.S. Use of sulfated fucans as anticoagulant and antithrombotic agents: Future perspectives. Curr. Pharm. Des. 2004, 10, 967–981. [Google Scholar] [CrossRef]
  34. Iwamoto, K.; Hiragun, T.; Takahagi, S.; Yanase, Y.; Morioke, S.; Mihara, S.; Kameyoshi, Y.; Hide, M. Fucoidan suppresses IgE production in peripheral blood mononuclear cells from patients with atopic dermatitis. Arch. Derm. Res. 2011, 303, 425–431. [Google Scholar] [CrossRef]
  35. Morioke, S.; Hiragun, T.; Yanase, Y.; Uchida, K.; Suzuki, H.; Iwamoto, K.; Hide, M. Cellulose sulfate suppresses immunoglobulin E production by murine B lymphocytes in vitro. J. Investig. Allergol. Clin. Immunol. 2012, 22, 180–187. [Google Scholar]
  36. Yang, J.H. Topical application of fucoidan improves atopic dermatitis symptoms in NC/Nga mice. Phytother. Res. PTR 2012, 26, 1898–1903. [Google Scholar] [CrossRef] [PubMed]
  37. Tian, T.; Chang, H.; He, K.; Ni, Y.; Li, C.; Hou, M.; Chen, L.; Xu, Z.; Chen, B.; Ji, M. Fucoidan from seaweed Fucus vesiculosus inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis. Int. Immunopharmacol. 2019, 75, 105823. [Google Scholar] [CrossRef] [PubMed]
  38. Pozharitskaya, O.N.; Shikov, A.N.; Obluchinskaya, E.D.; Vuorela, H. The Pharmacokinetics of Fucoidan after Topical Application to Rats. Mar. Drugs 2019, 17, 687. [Google Scholar] [CrossRef] [Green Version]
  39. Lee, W.R.; Park, J.H.; Kim, K.H.; Kim, S.J.; Park, D.H.; Chae, M.H.; Suh, S.H.; Jeong, S.W.; Park, K.K. The biological effects of topical alginate treatment in an animal model of skin wound healing. Wound Repair Regen. 2009, 17, 505–510. [Google Scholar] [CrossRef] [PubMed]
  40. Lu, W.; Bao, D.; Ta, F.; Liu, D.; Zhang, D.; Zhang, Z.; Fan, Z. Multifunctional Alginate Hydrogel Protects and Heals Skin Defects in Complex Clinical Situations. ACS Omega 2020, 5, 17152–17159. [Google Scholar] [CrossRef]
  41. Harrison, I.P.; Spada, F. Hydrogels for Atopic Dermatitis and Wound Management: A Superior Drug Delivery Vehicle. Pharmaceutics 2018, 10, 71. [Google Scholar] [CrossRef]
  42. Ghasemiyeh, P.; Mohammadi-Samani, S. Hydrogels as Drug Delivery Systems; Pros and Cons. Trends Pharm. Sci. 2019, 5, 7–24. [Google Scholar] [CrossRef]
  43. Menon, G.K.; Cleary, G.W.; Lane, M.E. The structure and function of the stratum corneum. Int. J. Pharm. 2012, 435, 3–9. [Google Scholar] [CrossRef]
  44. Alkilani, A.Z.; McCrudden, M.T.C.; Donnelly, R.F. Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum. Pharmaceutics 2015, 7, 438–470. [Google Scholar] [CrossRef] [Green Version]
  45. Barry, B.W. Lipid-Protein-Partitioning theory of skin penetration enhancement. J. Control. Release 1991, 15, 237–248. [Google Scholar] [CrossRef]
  46. Kapoor, M.S.; GuhaSarkar, S.; Banerjee, R. Stratum corneum modulation by chemical enhancers and lipid nanostructures: Implications for transdermal drug delivery. Ther. Deliv. 2017, 8, 701–718. [Google Scholar] [CrossRef] [PubMed]
  47. Kováčik, A.; Kopečná, M.; Vávrová, K. Permeation enhancers in transdermal drug delivery: Benefits and limitations. Expert Opin. Drug Deliv. 2020, 17, 145–155. [Google Scholar] [CrossRef] [PubMed]
  48. Lopes, L.B.; Garcia, M.T.J.; Bentley, M.V.L. Chemical penetration enhancers. Ther. Deliv. 2015, 6, 1053–1061. [Google Scholar] [CrossRef] [PubMed]
  49. Edris, A.E. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: A review. Phytother. Res. 2007, 21, 308–323. [Google Scholar] [CrossRef]
  50. Adorjan, B.; Buchbauer, G. Biological properties of essential oils: An updated review. Flavour Fragr. J. 2010, 25, 407–426. [Google Scholar] [CrossRef]
  51. Aggarwal, S.; Agarwal, S.; Jalhan, S. Essential oils as novel human skin penetration enhancer for transdermal drug delivery: A review. Int. J. Pharma Bio Sci. 2013, 4, 857–868. [Google Scholar]
  52. Sharifi-Rad, J.; Sureda, A.; Tenore, G.C.; Daglia, M.; Sharifi-Rad, M.; Valussi, M.; Tundis, R.; Sharifi-Rad, M.; Loizzo, M.R.; Ademiluyi, A.O.; et al. Biological Activities of Essential Oils: From Plant Chemoecology to Traditional Healing Systems. Molecules 2017, 22, 70. [Google Scholar] [CrossRef]
  53. Herman, A.; Herman, A.P. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: A review. J. Pharm. Pharmacol. 2015, 67, 473–485. [Google Scholar] [CrossRef]
  54. de Groot, A.C.; Schmidt, E. Essential Oils, Part III: Chemical Composition. Dermat. Contact Atopic Occup. Drug 2016, 27, 161–169. [Google Scholar] [CrossRef]
  55. Willia, A.C.; Barry, B.W. Terpenes and the Lipid–Protein–Partitioning Theory of Skin Penetration Enhancement. Pharm. Res. 1991, 8, 17–24. [Google Scholar] [CrossRef]
  56. Aqil, M.; Ahad, A.; Sultana, Y.; Ali, A. Status of terpenes as skin penetration enhancers. Drug Discov. Today 2007, 12, 1061–1067. [Google Scholar] [CrossRef]
  57. Kunta, J.R.; Goskonda, V.R.; Brotherton, H.O.; Khan, M.A.; Reddy, I.K. Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J. Pharm. Sci. 1997, 86, 1369–1373. [Google Scholar] [CrossRef] [PubMed]
  58. Fujii, M.; Takeda, Y.; Yoshida, M.; Utoguchi, N.; Matsumoto, M.; Watanabe, Y. Comparison of skin permeation enhancement by 3-l-menthoxypropane-1,2-diol and l-menthol: The permeation of indomethacin and antipyrine through Yucatan micropig skin and changes in infrared spectra and X-ray diffraction patterns of stratum corneum. Int. J. Pharm. 2003, 258, 217–223. [Google Scholar] [CrossRef] [PubMed]
  59. Nagai, N.; Ogata, F.; Yamaguchi, M.; Fukuoka, Y.; Otake, H.; Nakazawa, Y.; Kawasaki, N. Combination with l-menthol enhances transdermal penetration of indomethacin solid nanoparticles. Int. J. Mol. Sci. 2019, 20, 3644. [Google Scholar] [CrossRef] [Green Version]
  60. Hasnain, M.S.; Rishishwar, P.; Ali, S.; Alkahtani, S.; Tabish, M.; Milivojevic, M.; Ansari, M.T.; Nayak, A.K. Formulation and ex vivo skin permeation of lidocaine HCl topical gels using dillenia (Dillenia indica L.) fruit gum. Rev. Mex. Ing. Quim. 2020, 19, 1465–1476. [Google Scholar] [CrossRef]
  61. Burki, I.K.; Khan, M.K.; Khan, B.A.; Uzair, B.; Braga, V.A.; Jamil, Q.A. Formulation Development, Characterization, and Evaluation of a Novel Dexibuprofen-Capsaicin Skin Emulgel with Improved In Vivo Anti-inflammatory and Analgesic Effects. AAPS PharmSciTech 2020, 21, 211. [Google Scholar] [CrossRef] [PubMed]
  62. Peana, A.; Moretti, L. Linalool in Essential Plant Oils: Pharmacological Effects. Bot. Med. Clin. Pract. 2008, 10, 716–724. [Google Scholar] [CrossRef]
  63. Fang, J.Y.; Tsai, T.H.; Lin, Y.Y.; Wong, W.W.; Wang, M.N.; Huang, J.F. Transdermal delivery of tea catechins and theophylline enhanced by terpenes: A mechanistic study. Biol. Pharm. Bull. 2007, 30, 343–349. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Peana, A.T.; D’Aquila, P.S.; Panin, F.; Serra, G.; Pippia, P.; Moretti, M.D.L. Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils. Phytomedicine 2002, 9, 721–726. [Google Scholar] [CrossRef]
  65. Ceschel, G.C.; Maffei, P.; Moretti, M.D.; Demontis, S.; Peana, A.T. In vitro permeation through porcine buccal mucosa of Salvia desoleana Atzei & Picci essential oil from topical formulations. Int. J. Pharm. 2000, 195, 171–177. [Google Scholar] [CrossRef] [PubMed]
  66. Sawamura, M.; Onishi, Y.; Ikemoto, J.; Tu, N.T.M.; Phi, N.T.L. Characteristic odour components of bergamot (Citrus bergamia Risso) essential oil. Flavour Fragr. J. 2006, 21, 609–615. [Google Scholar] [CrossRef]
  67. Sakurada, T.; Mizoguchi, H.; Kuwahata, H.; Katsuyama, S.; Komatsu, T.; Morrone, L.; Corasaniti, M.; Bagetta, G.; Sakurada, S. Intraplantar injection of bergamot essential oil induces peripheral antinociception mediated by opioid mechanism. Pharmacol. Biochem. Behav. 2010, 97, 436–443. [Google Scholar] [CrossRef] [PubMed]
  68. Salehi, B.; Upadhyay, S.; Orhan, I.E.; Jugran, A.K.; Jayaweera, S.L.D.; Dias, D.A.; Sharopov, F.; Taheri, Y.; Martins, N.; Baghalpour, N.; et al. Therapeutic potential of α-and β-pinene: A miracle gift of nature. Biomolecules 2019, 9, 738. [Google Scholar] [CrossRef] [Green Version]
  69. Schmitt, S.; Schaefer, U.; Sporer, F.; Reichling, J. Comparative study on the in vitro human skin permeation of monoterpenes and phenylpropanoids applied in rose oil and in form of neat single compounds. Die Pharm. 2010, 65, 102–105. [Google Scholar] [CrossRef]
  70. Oh, J.-H.; Park, H.-H.; Do, K.-Y.; Han, M.; Hyun, D.-H.; Kim, C.-G.; Kim, C.-H.; Lee, S.S.; Hwang, S.-J.; Shin, S.-C.; et al. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein. Eur. J. Pharm. Biopharm. 2008, 69, 1040–1045. [Google Scholar] [CrossRef]
  71. Paun, V.A.; Popa, M.; Desbrieres, J.; Peptu, C.; Dragan, S.V.; Zegan, G.; Cioca, G. Liposome loaded chitosan hydrogels, a promising way to reduce the burst effect in drug release a comparativ analysis. Mater. Plast. 2016, 53, 590–593. [Google Scholar]
  72. Pereira, T.; Ramos, D.; Lopez, R. Hydrogel increases localized transport regions and skin permeability during low frequency ultrasound treatment. Sci. Rep. 2017, 7, 44236. [Google Scholar] [CrossRef] [Green Version]
  73. Barba, C.; Alonso, C.; Martí, M.; Carrer, V.; Yousef, I.; Coderch, L. Selective Modification of Skin Barrier Lipids. J. Pharm. Biomed. Anal. 2019, 172, 94–102. [Google Scholar] [CrossRef] [PubMed]
  74. Mansour, R.S.H.; Sallam, A.A.; Hamdan, I.I.; Khalil, E.A.; Yousef, I. Elucidation of Penetration Enhancement Mechanism of Emu Oil Using FTIR Microspectroscopy at EMIRA Laboratory of SESAME Synchrotron. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2017, 185, 1–10. [Google Scholar] [CrossRef]
  75. Rippke, F.; Schreiner, V.; Doering, T.; Maibach, H.I. Stratum corneum pH in atopic dermatitis: Impact on skin barrier function and colonization with Staphylococcus Aureus. Am. J. Clin. Dermatol. 2004, 5, 217–223. [Google Scholar] [CrossRef] [PubMed]
  76. Feingold, K.R. The outer frontier: The importance of lipid metabolism in the skin. J. Lipid. Res. 2009, 50, S417–S422. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Knudsen, N.Ø.; Pedersen, G.P. PH and Drug Delivery. In Current Problems in Dermatology; S. Karger AG: Basel, Switzerland, 2018; Volume 54, pp. 143–151. [Google Scholar]
  78. Lambers, H.; Piessens, S.; Bloem, A.; Pronk, H.; Finkel, P. Natural skin surface pH Is on average below 5, which is beneficial for its resident flora. Int. J. Cosmet. Sci. 2006, 28, 359–370. [Google Scholar] [CrossRef] [PubMed]
  79. Zeng, H.-Y.; Huang, Y.-C. Basic fibroblast growth factor released from fucoidan-modified chitosan/alginate scaffolds for promoting fibroblasts migration. J. Polym. Res. 2018, 25, 83. [Google Scholar] [CrossRef]
  80. Mantha, S.; Pillai, S.; Khayambashi, P.; Upadhyay, A.; Zhang, Y.; Tao, O.; Pham, H.M.; Tran, S.D. Smart Hydrogels in Tissue Engineering and Regenerative Medicine. Materials 2019, 12, 3323. [Google Scholar] [CrossRef] [Green Version]
  81. Bialik-Wąs, K.; Pluta, K.; Malina, D.; Barczewski, M.; Malarz, K.; Mrozek-Wilczkiewicz, A. Advanced SA/PVA-based hydrogel matrices with prolonged release of Aloe vera as promising wound dressings. Mater. Sci. Eng. C 2021, 120, 111667. [Google Scholar] [CrossRef]
  82. Saravana, P.S.; Cho, Y.N.; Patil, M.P.; Cho, Y.J.; Kim, G.D.; Park, Y.B.; Woo, H.C.; Chun, B.S. Hydrothermal degradation of seaweed polysaccharide: Characterization and biological activities. Food Chem. 2018, 268, 179–187. [Google Scholar] [CrossRef]
  83. Trivedi, M.; Patil, S.; Mishra, R.; Jana, S. Structural and Physical Properties of Biofield Treated Thymol and Menthol. Mol. Pharm. Org. Process Res. 2015, 3, 1000127. [Google Scholar] [CrossRef]
  84. Fantin, G.; Fogagnolo, M.; Maietti, S.; Rossetti, S. Selective Removal of Monoterpenes from Bergamot Oil by Inclusion in Deoxycholic Acid. J. Agric. Food Chem. 2010, 58, 5438–5443. [Google Scholar] [CrossRef] [PubMed]
  85. Kfoury, M.; Auezova, L.; Fourmentin, S.; Greige-Gerges, H. Investigation of monoterpenes complexation with hydroxypropyl-β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 2014, 80, 51–60. [Google Scholar] [CrossRef]
  86. Antunes, J.C.; Tavares, T.D.; Teixeira, M.A.; Teixeira, M.O.; Homem, N.C.; Amorim, M.T.P.; Felgueiras, H.P. Eugenol-Containing Essential Oils Loaded onto Chitosan/Polyvinyl Alcohol Blended Films and Their Ability to Eradicate Staphylococcus aureus or Pseudomonas aeruginosa from Infected Microenvironments. Pharmaceutics 2021, 13, 195. [Google Scholar] [CrossRef]
  87. Lee, C.H.; Moturi, V.; Lee, Y. Thixotropic property in pharmaceutical formulations. J. Control. Release 2009, 136, 88–98. [Google Scholar] [CrossRef]
  88. Carvalho, F.C.; Calixto, G.; Hatakeyama, I.N.; Luz, G.M.; Gremião, M.P.D.; Chorilli, M. Rheological, mechanical, and bioadhesive behavior of hydrogels to optimize skin delivery systems. Drug Dev. Ind. Pharm. 2013, 39, 1750–1757. [Google Scholar] [CrossRef]
  89. Ghica, M.; Hirjau, M.; Lupuleasa, D.; Dinu-Pîrvu, C.-E. Flow and Thixotropic Parameters for Rheological Characterization of Hydrogels. Molecules 2016, 21, 786. [Google Scholar] [CrossRef] [PubMed]
  90. Brummer, R.; Griebenow, M.; Hetzel, F.; Uhlmann, R. Rheological swing test to predict the temperature stability of cosmetic emulsions. In Proceedings of the 21st IFSCC Congress, Berlin, Germany, 11–14 September 2000. [Google Scholar]
  91. Herbig, M.E.; Houdek, P.; Gorissen, S.; Zorn-Kruppa, M.; Wladykowski, E.; Volksdorf, T.; Grzybowski, S.; Kolios, G.; Willers, C.; Mallwitz, H.; et al. A custom tailored model to investigate skin penetration in porcine skin and its comparison with human skin. Eur. J. Pharm. Biopharm. 2015, 95, 99–109. [Google Scholar] [CrossRef]
  92. Dick, I.P.; Scott, R.C. Pig Ear Skin as an In-Vitro Model for Human Skin Permeability. J. Pharm. Pharmacol. 1992, 44, 640–645. [Google Scholar] [CrossRef]
  93. Barradas, T.N.; Senna, J.P.; Cardoso, S.A.; Nicoli, S.; Padula, C.; Santi, P.; Rossi, F.; de Holanda e Silva, K.G.; Mansur, C.R.E. Hydrogel-thickened nanoemulsions based on essential oils for topical delivery of psoralen: Permeation and stability studies. Eur. J. Pharm. Biopharm. 2017, 116, 38–50. [Google Scholar] [CrossRef]
  94. Serra, E.; Saubade, F.; Ligorio, C.; Whitehead, K.; Sloan, A.; Williams, D.W.; Hidalgo-Bastida, A.; Verran, J.; Malic, S. Methylcellulose Hydrogel with Melissa officinalis Essential Oil as a Potential Treatment for Oral Candidiasis. Microorganisms 2020, 8, 215. [Google Scholar] [CrossRef] [Green Version]
  95. Valussi, M.; Donelli, D.; Firenzuoli, F.; Antonelli, M. Bergamot Oil: Botany, Production, Pharmacology. Encyclopedia 2021, 1, 152–176. [Google Scholar] [CrossRef]
  96. Nagle, A.; Goyal, A.K.; Kesarla, R.; Murthy, R.R. Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model. J. Liposome. Res. 2011, 21, 134–140. [Google Scholar] [CrossRef] [PubMed]
  97. Pappas, A. Epidermal surface lipids. Dermatoendocrinology 2009, 1, 72–76. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  98. Mendelsohn, R.; Flach, C.R.; Moore, D.J. Determination of molecular conformation and permeation in skin via IR spectroscopy, microscopy, and imaging. Biochim. Biophys. Acta (BBA)-Biomembr. 2006, 1758, 923–933. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  99. Golden, G.M.; Guzek, D.B.; Harris, R.R.; McKie, J.E.; Potts, R.O. Lipid thermotropic transitions in human stratum corneum. J. Investig. Derm. 1986, 86, 255–259. [Google Scholar] [CrossRef] [Green Version]
  100. Boncheva, M.; Damien, F.; Normand, V. Molecular organization of the lipid matrix in intact stratum corneum using ATR-FTIR spectroscopy. Biochim. Biophys. Acta 2008, 1778, 1344–1355. [Google Scholar] [CrossRef] [Green Version]
  101. Wetzel, D.L.; LeVine, S.M. Biological Application of Infrared Microspectroscopy; Marcel Dekker: New York, NY, USA, 2001. [Google Scholar]
  102. Barry, B.W. Action of skin penetration enhancers—The Lipid Protein Partitioning theory. Int. J. Cosmet. Sci. 1988, 10, 281–293. [Google Scholar] [CrossRef]
  103. Knox, S.; O’Boyle, N.M. Skin lipids in health and disease: A review. Chem. Phys. Lipids 2021, 236, 105055. [Google Scholar] [CrossRef] [PubMed]
  104. Deo, P.N.; Deshmukh, R. Pathophysiology of keratinization. J. Oral Maxillofac. Pathol. JOMFP 2018, 22, 86–91. [Google Scholar] [CrossRef]
Pharmaceutics 15 00190 g001 550
Figure 1. SEM micrographs of hydrogels (top scale bars: 500 µm; bottom scale bars: 20 µm).
Figure 1. SEM micrographs of hydrogels (top scale bars: 500 µm; bottom scale bars: 20 µm).
Pharmaceutics 15 00190 g001
Pharmaceutics 15 00190 g002 550
Figure 2. Offset thermograms of hydrogel components (a) and all hydrogels (b).
Figure 2. Offset thermograms of hydrogel components (a) and all hydrogels (b).
Pharmaceutics 15 00190 g002
Pharmaceutics 15 00190 g003 550
Figure 3. Viscosimetry analysis of (a) alginate/fucoidan, (b) menthol-alginate/fucoidan, (c) linalool-alginate/fucoidan, (d) bergamot-alginate/fucoidan, and (e) pinene-alginate/fucoidan. Data expressed as mean ± SD of n = 3 different hydrogel batches.
Figure 3. Viscosimetry analysis of (a) alginate/fucoidan, (b) menthol-alginate/fucoidan, (c) linalool-alginate/fucoidan, (d) bergamot-alginate/fucoidan, and (e) pinene-alginate/fucoidan. Data expressed as mean ± SD of n = 3 different hydrogel batches.
Pharmaceutics 15 00190 g003
Pharmaceutics 15 00190 g004 550
Figure 4. Thixotropy analysis of (a) alginate/fucoidan, (b) menthol-alginate/fucoidan, (c) linalool-alginate/fucoidan, (d) bergamot-alginate/fucoidan, and (e) pinene-alginate/fucoidan. Data expressed as mean ± SD of n = 3 different hydrogel batches.
Figure 4. Thixotropy analysis of (a) alginate/fucoidan, (b) menthol-alginate/fucoidan, (c) linalool-alginate/fucoidan, (d) bergamot-alginate/fucoidan, and (e) pinene-alginate/fucoidan. Data expressed as mean ± SD of n = 3 different hydrogel batches.
Pharmaceutics 15 00190 g004
Pharmaceutics 15 00190 g005 550
Figure 5. Apparent permeability at 24 h through pig ear skin for all tested sample conditions. Data expressed as mean ± standard deviation of n = 3 replicates. * p < 0.05; ** p < 0.01; *** p < 0.001.
Figure 5. Apparent permeability at 24 h through pig ear skin for all tested sample conditions. Data expressed as mean ± standard deviation of n = 3 replicates. * p < 0.05; ** p < 0.01; *** p < 0.001.
Pharmaceutics 15 00190 g005
Pharmaceutics 15 00190 g006 550
Figure 6. Evaluation of the amide I and amide II keratin band shifts in all essential oils and essential-oil-enriched hydrogels in comparison to the untreated sample, organized as menthol-alginate/fucoidan (a), linalool-alginate/fucoidan (b), bergamot-alginate/fucoidan (c), and pinene-alginate/fucoidan (d).
Figure 6. Evaluation of the amide I and amide II keratin band shifts in all essential oils and essential-oil-enriched hydrogels in comparison to the untreated sample, organized as menthol-alginate/fucoidan (a), linalool-alginate/fucoidan (b), bergamot-alginate/fucoidan (c), and pinene-alginate/fucoidan (d).
Pharmaceutics 15 00190 g006
Table
Table 1. Evaluation of the lipid CH2 and CH3 stretching band shifts in all essential oils and essential-oil-enriched hydrogels.
Table 1. Evaluation of the lipid CH2 and CH3 stretching band shifts in all essential oils and essential-oil-enriched hydrogels.
CH2 (cm−1)CH3 (cm−1)
SymmetricAsymmetricSymmetricAsymmetric
Menthol2852292228712958
Linalool2852292028712958
Bergamot2850292428732958
Pinene2850291828712958
Untreated2852292528712962
Alginate/fucoidan2850292228712958
Menthol-alginate/fucoidan2850292028712958
Linalool-alginate/fucoidan2850292228712956
Bergamot-alginate/fucoidan2850292028732960
Pinene-alginate/fucoidan2852292028732960
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Barbosa, A.I.; Lima, S.A.C.; Yousef, I.; Reis, S. Evaluating the Skin Interactions and Permeation of Alginate/Fucoidan Hydrogels Per Se and Associated with Different Essential Oils. Pharmaceutics 2023, 15, 190. https://doi.org/10.3390/pharmaceutics15010190

AMA Style

Barbosa AI, Lima SAC, Yousef I, Reis S. Evaluating the Skin Interactions and Permeation of Alginate/Fucoidan Hydrogels Per Se and Associated with Different Essential Oils. Pharmaceutics. 2023; 15(1):190. https://doi.org/10.3390/pharmaceutics15010190

Chicago/Turabian Style

Barbosa, Ana Isabel, Sofia A. Costa Lima, Ibraheem Yousef, and Salette Reis. 2023. "Evaluating the Skin Interactions and Permeation of Alginate/Fucoidan Hydrogels Per Se and Associated with Different Essential Oils" Pharmaceutics 15, no. 1: 190. https://doi.org/10.3390/pharmaceutics15010190

APA Style

Barbosa, A. I., Lima, S. A. C., Yousef, I., & Reis, S. (2023). Evaluating the Skin Interactions and Permeation of Alginate/Fucoidan Hydrogels Per Se and Associated with Different Essential Oils. Pharmaceutics, 15(1), 190. https://doi.org/10.3390/pharmaceutics15010190

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop